MedPath

MINJUVI 200 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION

MINJUVI 200 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION

Commercialized
Register Number

1211570001

Prescription Type

Uso Hospitalario

Authorization Date

Sep 28, 2021

Dosage Form

POLVO PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN

Route: VÍA INTRAVENOSA

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number1211570001
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
Yes
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

TAFASITAMABActive
Quantity: 200 mg
Name: TAFASITAMAB

ATC CLASSIFICATION (3)

L01F
L01FX
L01FX12

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.